FTC Sends Allergan, Valeant Second Info Request
Allergan Inc. and Valeant Pharmaceuticals Inc. said Monday they have received a second request for information from the Federal Trade Commission as the antitrust regulator increases its scrutiny of Valeant's and...To view the full article, register now.
Already a subscriber? Click here to view full article